Two-Day Arthritis Adcom to Look at Cart and Horse
By Mari Serebrov
Friday, July 19, 2013
In what could become a textbook example of putting the cart alongside the horse, the FDA will ask its Arthritis Advisory Committee Monday to consider whether the data are sufficient to make axial spondyloarthritis (SpA), as defined by the Assessment of Spondyloarthritis International Society (ASAS) criteria, a new indication for arthritis drugs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.